Tulipas, Ayesha Jellica C.
HRN: 21-51-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
CEFUROXIME 1.5GM (VIAL)
06/25/2022
07/02/2022
IVT
1.5g
Q8H
For D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes